| No. | Document Title | ID | Updated | Views |
|---|---|---|---|---|
| 21 | Step | 101813 | 2022-12-02 | 325 |
| 22 | Exempt (if applicable) | 101811 | 2022-12-02 | 312 |
| 23 | Expanded Access Status | 101810 | 2022-12-02 | 323 |
| 24 | Expanded Access | 101809 | 2022-12-02 | 313 |
| 25 | IND/IDE: Expiration Date | 101807 | 2022-12-02 | 334 |
| 26 | FDA Approval Date | 101806 | 2022-12-02 | 361 |
| 27 | IND/IDE Submit Date | 101805 | 2022-12-02 | 294 |
| 28 | Grantor | 101804 | 2022-12-02 | 283 |
| 29 | NCI/NIH Institution | 101803 | 2022-12-02 | 307 |
| 30 | Investigational Drug/Device | 101800 | 2022-12-02 | 291 |
| 31 | Fund Account No. | 101797 | 2022-11-29 | 404 |
| 32 | Sponsor Protocol No. | 101796 | 2022-11-29 | 310 |
| 33 | Sponsor Type | 101795 | 2022-11-29 | 372 |
| 34 | Managment Group | 101788 | 2022-11-29 | 363 |
| 35 | Toxicity Scheme | 24235 | 2022-11-25 | 441 |
| 36 | IRB Committee | 101848 | 2022-11-17 | 280 |
| 37 | IRB: Submit Date | 101847 | 2022-11-17 | 321 |
| 38 | Subject MRN | 23831 | 2022-11-09 | 565 |
| 39 | Verified By | 99349 | 2022-10-05 | 410 |
| 40 | Version Date | 99348 | 2022-10-05 | 333 |
Not finding what you are looking for? Suggest a new document be created, or try adjusting your search criteria.